These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 24379606)

  • 1. Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma.
    Bacigalupo ML; Manzi M; Rabinovich GA; Troncoso MF
    World J Gastroenterol; 2013 Dec; 19(47):8831-49. PubMed ID: 24379606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Li H; Wu K; Tao K; Chen L; Zheng Q; Lu X; Liu J; Shi L; Liu C; Wang G; Zou W
    Hepatology; 2012 Oct; 56(4):1342-51. PubMed ID: 22505239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Galectin-1 and Galectin-3 in hepatocellular carcinoma.
    Setayesh T; Colquhoun SD; Wan YY
    Liver Res; 2020 Dec; 4(4):173-179. PubMed ID: 34567824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma.
    Hsu DK; Dowling CA; Jeng KC; Chen JT; Yang RY; Liu FT
    Int J Cancer; 1999 May; 81(4):519-26. PubMed ID: 10225438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of galectin-1 exacerbates chronic hepatitis, liver fibrosis, and carcinogenesis in murine hepatocellular carcinoma model.
    Potikha T; Pappo O; Mizrahi L; Olam D; Maller SM; Rabinovich GA; Galun E; Goldenberg DS
    FASEB J; 2019 Jul; 33(7):7995-8007. PubMed ID: 30897344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis.
    Ma WL; Lai HC; Yeh S; Cai X; Chang C
    Endocr Relat Cancer; 2014 Jun; 21(3):R165-82. PubMed ID: 24424503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified AS1411 Aptamer Suppresses Hepatocellular Carcinoma by Up-Regulating Galectin-14.
    Cho Y; Lee YB; Lee JH; Lee DH; Cho EJ; Yu SJ; Kim YJ; Kim JI; Im JH; Lee JH; Oh EJ; Yoon JH
    PLoS One; 2016; 11(8):e0160822. PubMed ID: 27494117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis.
    Chen S; Pu J; Bai J; Yin Y; Wu K; Wang J; Shuai X; Gao J; Tao K; Wang G; Li H
    J Exp Clin Cancer Res; 2018 Jan; 37(1):3. PubMed ID: 29316949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory microenvironment of fibrotic liver promotes hepatocellular carcinoma growth, metastasis and sorafenib resistance through STAT3 activation.
    Jiang Y; Chen P; Hu K; Dai G; Li J; Zheng D; Yuan H; He L; Xie P; Tu M; Peng S; Qu C; Lin W; Chung RT; Hong J
    J Cell Mol Med; 2021 Feb; 25(3):1568-1582. PubMed ID: 33410581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment.
    Vilchez V; Turcios L; Marti F; Gedaly R
    World J Gastroenterol; 2016 Jan; 22(2):823-32. PubMed ID: 26811628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and prognostic value of galectin-9 in hepatocellular carcinoma patients].
    Gu CJ; Wu H; Sheng CY; Ni QC
    Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(26):2025-8. PubMed ID: 24169278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
    Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
    J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms.
    Esparza-Baquer A; Labiano I; Sharif O; Agirre-Lizaso A; Oakley F; Rodrigues PM; Zhuravleva E; O'Rourke CJ; Hijona E; Jimenez-Agüero R; Riaño I; Landa A; La Casta A; Zaki MYW; Munoz-Garrido P; Azkargorta M; Elortza F; Vogel A; Schabbauer G; Aspichueta P; Andersen JB; Knapp S; Mann DA; Bujanda L; Banales JM; Perugorria MJ
    Gut; 2021 Jul; 70(7):1345-1361. PubMed ID: 32907830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis.
    Berasain C; Avila MA
    J Gastroenterol; 2014 Jan; 49(1):9-23. PubMed ID: 24318021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implication of the Hedgehog pathway in hepatocellular carcinoma.
    Della Corte CM; Viscardi G; Papaccio F; Esposito G; Martini G; Ciardiello D; Martinelli E; Ciardiello F; Morgillo F
    World J Gastroenterol; 2017 Jun; 23(24):4330-4340. PubMed ID: 28706416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathways and gene expression profiles in hepatocellular carcinoma.
    Facciorusso A; Nacchiero MC; Rosania R; Laonigro G; Giorgio F; Del Prete V; Panella C; Ierardi E
    Minerva Gastroenterol Dietol; 2012 Mar; 58(1):35-48. PubMed ID: 22419003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between serum galectin-9 levels and liver fibrosis.
    Fujita K; Niki T; Nomura T; Oura K; Tadokoro T; Sakamoto T; Tani J; Yoneyama H; Morishita A; Kuroda N; Arai T; Nishimoto N; Himoto T; Hirashima M; Masaki T
    J Gastroenterol Hepatol; 2018 Feb; 33(2):492-499. PubMed ID: 28618039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of serum galectin-3 levels in patients with hepatocellular cancer and chronic viral hepatitis.
    Ulu M; Alacacioglu A; Yuksel E; Pamukk BO; Bozkaya G; Ari A; Yuksel A; Sop G; Alacacioglu I
    Saudi J Gastroenterol; 2015; 21(1):47-50. PubMed ID: 25672239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma.
    Hernandez-Gea V; Toffanin S; Friedman SL; Llovet JM
    Gastroenterology; 2013 Mar; 144(3):512-27. PubMed ID: 23313965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SHP2 is induced by the HBx-NF-κB pathway and contributes to fibrosis during human early hepatocellular carcinoma development.
    Kang HJ; Chung DH; Sung CO; Yoo SH; Yu E; Kim N; Lee SH; Song JY; Kim CJ; Choi J
    Oncotarget; 2017 Apr; 8(16):27263-27276. PubMed ID: 28460481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.